by GlobeNewsWire | Nov 1, 2017 | Globe Newswire
CAMBRIDGE, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, today announced the pricing of an...
by GlobeNewsWire | Nov 1, 2017 | Globe Newswire
NEWTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic...
by GlobeNewsWire | Nov 1, 2017 | Globe Newswire
NEW YORK, Nov. 01, 2017 (GLOBE NEWSWIRE) — Resource Capital Corp. (NYSE:RSO) Significant Items and Highlights GAAP net income allocable to common shares of $0.41 and $0.57 per share-diluted for the three and nine months ended September 30, 2017,...
by GlobeNewsWire | Nov 1, 2017 | Globe Newswire
CALGARY, Alberta, Nov. 01, 2017 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or “the Company”) is pleased to report its financial and operating results for the three and nine months ended September 30, 2017. The unaudited condensed...
by GlobeNewsWire | Nov 1, 2017 | Globe Newswire
VANCOUVER, British Columbia, Nov. 01, 2017 (GLOBE NEWSWIRE) — Galileo Exploration Ltd. (TSX Venture Exchange:GXL) (the “Company”) provides the following additional disclosure in relation to the private placement financing which closed as previously...